University of Helsinki
Recent research from the University of Helsinki sheds new light on the behaviour of the KRAS gene in two of the deadliest cancers-pancreatic and colorectal cancer. These findings suggest potential pathways for targeted therapies in KRAS-driven cancers.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
